Anygen

Anygen is a South Korean biotechnology company specializing in the development and manufacture of peptide-based medicines. Founded in 2000 as a spin-off from the Gwangju Institute of Science and Technology, the company operates as a premier Contract Development and Manufacturing Organization (CDMO) for peptides. Anygen's core business includes the production of high-quality peptide Active Pharmaceutical Ingredients (APIs) and the development of a proprietary drug pipeline targeting metabolic diseases and oncology. The company maintains state-of-the-art GMP-certified facilities capable of both solid-phase and liquid-phase peptide synthesis. Anygen is publicly traded on the KOSDAQ exchange and continues to expand its global footprint through strategic partnerships and innovative peptide engineering technologies.